Year archive

UCB — 2013 filings

All 132 regulatory filings released by UCB (UCB) in 2013, sourced directly from the official regulator.

132 Filings

2013 Period

2013 filings (132)

Filing	Released	Lang
Acquisition of own shares_E (09-12).pdf Transaction in Own Shares	2013-12-10	English
Acquisition of own shares_FR (09-12).pdf Transaction in Own Shares	2013-12-10	French
Acquisition of own shares_NL (09-12).pdf Transaction in Own Shares	2013-12-10	Dutch
UCB 9 month interim report ENG.pdf Interim / Quarterly Report 9M 2013	2013-10-25	English
UCB 9 month interim report FR.pdf Interim / Quarterly Report 9M 2013	2013-10-25	French
UCB 9 month interim report NL.pdf Interim / Quarterly Report 9M 2013	2013-10-25	Dutch
Cimzia® (certolizumab pegol) Approved by FDA for Treatment of Adults with Active Ankylosing Spondylitis Regulatory Filings	2013-10-18	English
Cimzia® (certolizumab pegol) approuvé par la FDA dans le traitement des adultes atteints de spondylarthrite ankylosante active Regulatory Filings	2013-10-18	French
Cimzia® (certolizumab pegol ) door de Amerikaanse FDA goedgekeurd voor de behandeling van volwassenen met actieve ankylopoetica spondylitis Legal Proceedings Report	2013-10-18	Dutch
Cimzia® (certolizumab pegol) approved by the U.S. FDA for treatment of adult patients with active psoriatic arthritis Regulatory Filings	2013-09-30	English
Cimzia® (certolizumab pegol) approuvé par la FDA dans le traitement des patients adultes atteints de rhumatisme psoriasique actif Regulatory Filings	2013-09-30	French
Cimzia® (certolizumab pegol ) door de Amerikaanse FDA goedgekeurd voor de behandeling van volwassen patiënten met actieve psoriatische artritis Legal Proceedings Report	2013-09-30	Dutch
UCB institutional bonds completion UK Capital/Financing Update	2013-09-27	English
UCB institutional bonds completion FR Capital/Financing Update	2013-09-27	French
UCB institutional bonds completion NL Capital/Financing Update	2013-09-27	Dutch
UCB Institutional Bonds offering UK Capital/Financing Update	2013-09-27	English
UCB Institutional Bonds offering FR Capital/Financing Update	2013-09-27	French
UCB Institutional Bonds offering NL Capital/Financing Update	2013-09-27	Dutch
Results of the public exchange offer on the bonds maturing in November 2014 Capital/Financing Update	2013-09-20	English
Résultats de l’offre publique d’échange sur les obligations venant à échéance en novembre 2014 Capital/Financing Update	2013-09-20	French
Resultaten van het openbaar aanbod tot omruiling van de obligaties met vervaldatum in november 2014 Capital/Financing Update	2013-09-20	Dutch
UCB receives CHMP positive opinion for Cimzia® in severe active axial spondyloarthritis Regulatory Filings	2013-09-20	English
UCB reçoit l’avis positif du CHMP pour l’emploi de Cimzia® dans le traitement de la spondylarthrite axiale active sévère Regulatory Filings	2013-09-20	French
UCB krijgt positieve beoordeling van CHMP voor Cimzia® bij ernstige actieve axiale spondyloartritis Regulatory Filings	2013-09-20	Dutch
Acquisition of own shares_ENG (18-09).pdf Transaction in Own Shares	2013-09-18	English
Acquisition of own shares_FR (18-09).pdf Transaction in Own Shares	2013-09-18	French
Acquisition of own shares_NL (18-09).pdf Transaction in Own Shares	2013-09-18	Dutch
UCB launches a public exchange offer on its bonds maturing in November 2014 Capital/Financing Update	2013-09-03	English
UCB lance une offre publique d’échange sur ses obligations venant à échéance en novembre 2014 Capital/Financing Update	2013-09-03	French
UCB lanceert een openbaar aanbod tot omruiling van haar obligaties met vervaldatum in november 2014 Capital/Financing Update	2013-09-03	Dutch
UCB files a public exchange offer on its bonds maturing in November 2014 Capital/Financing Update	2013-09-03	English
UCB se propose d’effectuer une offre publique d’échange sur ses obligations venant à échéance en novembre 2014 Capital/Financing Update	2013-09-03	French
UCB dient een openbaar aanbod tot omruiling in van haar obligaties met vervaldatum in november 2014 Capital/Financing Update	2013-09-03	Dutch
UCB half year results 2013 UK.pdf Earnings Release H1 2013	2013-07-31	English
UCB half year results 2013 FR.pdf Interim / Quarterly Report H1 2013	2013-07-31	French
UCB half year results 2013 NL.pdf Interim / Quarterly Report H1 2013	2013-07-31	Dutch
2013 HY management report - ENG_FINAL.pdf Interim / Quarterly Report H1 2013	2013-07-31	English
2013 HY management report - FR.pdf Interim / Quarterly Report H1 2013	2013-07-31	French
2013 HY management report - NL.pdf Interim / Quarterly Report H1 2013	2013-07-31	Dutch
20130724 - Transparency notification of Capital - ENG.pdf Major Shareholding Notification	2013-07-30	English
20130724 - Transparency notification of Capital - FR.pdf Major Shareholding Notification	2013-07-30	French
20130724 - Transparency notification of Capital - NL.pdf Major Shareholding Notification	2013-07-30	Dutch
20130724 - Transparency notification of Capital - ENG.pdf Major Shareholding Notification	2013-07-30	English
20130724 - Transparency notification of Capital - FR.pdf Major Shareholding Notification	2013-07-30	French
20130724 - Transparency notification of Capital - NL.pdf Major Shareholding Notification	2013-07-30	Dutch
UCB US FDA Advisory Board AxSpa UK Regulatory Filings	2013-07-24	English
UCB US FDA Advisory Board AxSpa FR Regulatory Filings	2013-07-24	French
UCB US FDA Advisory Board AxSpa NL Legal Proceedings Report	2013-07-24	Dutch
UCB's Kremers Urban Pharmaceuticals Inc. receives FDA approval for extended release methylphenidate hydrochloride Regulatory Filings	2013-07-10	English
Kremers Urban Pharmaceuticals Inc. (d’UCB) obtient l’autorisation de la FDA pour le chlorhydrate de méthylphénidate à libération prolongée Regulatory Filings	2013-07-10	French
UCB’s Kremers Urban Pharmaceuticals Inc. krijgt FDA-goedkeuring voor methylfenidaat hydrochloride met verlengde afgifte Legal Proceedings Report	2013-07-10	Dutch
Acquisition of own shares_ENG (04-07).pdf Transaction in Own Shares	2013-07-04	English
Acquisition of own shares_FR (04-07).pdf Transaction in Own Shares	2013-07-04	French
Acquisition of own shares_NL (04-07).pdf Transaction in Own Shares	2013-07-04	Dutch
UCB to out-license olokizumab to R-Pharm M&A Activity	2013-07-04	English
UCB cède à R-Pharm son droit d’exploitation sur l’olokizumab Capital/Financing Update	2013-07-04	French
UCB geeft olokizumab in licentie aan R-Pharm M&A Activity	2013-07-04	Dutch
20130614 - share capital UK.pdf Declaration of Voting Results & Voting Rights Announcements	2013-06-14	English
20130614 - share capital FR.pdf Share Issue/Capital Change	2013-06-14	French
20130614 - share capital NL.pdf Share Issue/Capital Change	2013-06-14	Dutch
20130612 - Transparency notification of Vanguard - ENG.pdf Major Shareholding Notification	2013-06-12	English
20130612 - Transparency notification of Vanguard - FR.pdf Major Shareholding Notification	2013-06-12	French
20130612 - Transparency notification of Vanguard - NL.pdf Director's Dealing	2013-06-12	Dutch
UCB to secure long-term partnership with UNITHER Pharmaceuticals for its Rochester manufacturing facility Regulatory Filings	2013-05-29	English
UCB conclut avec UNITHER Pharmaceuticals un partenariat à long terme pour son usine de production à Rochester M&A Activity	2013-05-29	French
UCB sluit langetermijnpartnerschap met UNITHER Pharmaceuticals voor productiefaciliteit in Rochester Regulatory Filings	2013-05-29	Dutch
Transparency notification of Capital May 2013 - ENG.pdf Major Shareholding Notification	2013-05-24	English
Transparency notification of Capital May 2013 - FR.pdf Major Shareholding Notification	2013-05-24	French
Transparency notification of Capital May 2013 - NL.pdf Major Shareholding Notification	2013-05-24	Dutch
Acquisition of own shares_ENG (09-05).pdf Transaction in Own Shares	2013-05-09	English
Acquisition of own shares_FR (09-05).pdf Transaction in Own Shares	2013-05-09	French
Acquisition of own shares_NL (09-05).pdf Transaction in Own Shares	2013-05-09	Dutch
UCB 3m Interim report (UK).pdf Interim / Quarterly Report Q1 2013	2013-04-25	English
UCB 3m Interim report (FR).pdf Interim / Quarterly Report Q1 2013	2013-04-25	French
UCB 3m Interim report (NL).pdf Interim / Quarterly Report Q1 2013	2013-04-25	Dutch
Acquisition of own shares_ENG (28-03).pdf Transaction in Own Shares	2013-03-28	English
Acquisition of own shares_FR (28-03).pdf Transaction in Own Shares	2013-03-28	French
Acquisition of own shares_NL (28-03).pdf Transaction in Own Shares	2013-03-28	Dutch
Annual accounts UCB SA.pdf Annual Report FY 2012	2013-03-26	English
Auditor's report UCB S.A. - FR.pdf Audit Report / Information FY 2012	2013-03-26	French
Annual accounts UCB S.A. - NL.pdf Annual Report FY 2012	2013-03-26	Dutch
Report of the Board - E.pdf AGM Information	2013-03-26	English
Formalités de participation.pdf AGM Information	2013-03-26	French
Report of the Board - NL.pdf Annual Report FY 2012	2013-03-26	Dutch
Proxy - E.pdf Proxy Solicitation & Information Statement	2013-03-26	English
Report of the Board - FR.pdf AGM Information	2013-03-26	French
Proxy - NL.pdf Proxy Solicitation & Information Statement	2013-03-26	Dutch
Attendance formalities.pdf AGM Information	2013-03-26	English
Proxy - FR.pdf AGM Information	2013-03-26	French
Formaliteiten voor deelname.pdf AGM Information	2013-03-26	Dutch
Auditor's report UCB S.A. - E.pdf Audit Report / Information FY 2012	2013-03-26	English
Annual accounts UCB S.A. - FR.pdf Annual Report FY 2012	2013-03-26	French
Auditor's report UCB S.A. - NL.pdf Audit Report / Information FY 2012	2013-03-26	Dutch
Convocation - E.pdf AGM Information	2013-03-26	English
Convocation - FR.pdf AGM Information	2013-03-26	French
Convocation - NL.pdf AGM Information	2013-03-26	Dutch
Acquisition of own shares_ENG (14-03).pdf Transaction in Own Shares	2013-03-14	English
Acquisition of own shares_FR (14-03).pdf Transaction in Own Shares	2013-03-14	French
Acquisition of own shares_NL (14-03).pdf Transaction in Own Shares	2013-03-14	Dutch
Acquisition of own shares_ENG (11-03).pdf Transaction in Own Shares	2013-03-11	English
Acquisition of own shares_FR (11-03).pdf Transaction in Own Shares	2013-03-11	French
Acquisition of own shares_NL (11-03).pdf Transaction in Own Shares	2013-03-11	Dutch
UCB EMTN Closing UK Capital/Financing Update	2013-03-11	English
UCB EMTN Closing FR Capital/Financing Update	2013-03-11	French
UCB EMTN Closing NL Capital/Financing Update	2013-03-11	Dutch
UCB EMTN UK Capital/Financing Update	2013-03-07	English
UCB EMTN FR Capital/Financing Update	2013-03-07	French
UCB EMTN NL Capital/Financing Update	2013-03-07	Dutch
UCB Vimpat US Monotherapy UK Earnings Release Q1 2013	2013-03-05	English
UCB Vimpat US Monotherapy FR Regulatory Filings	2013-03-05	French
UCB Vimpat US Monotherapy NL Earnings Release Q1 2013	2013-03-05	Dutch
2012_Annual_Report _ENG.pdf Annual Report FY 2012	2013-02-27	English
2012_Annual_Report_FR.pdf Governance Information	2013-02-27	French
2012_Annual_Report_NL.pdf Annual Report FY 2012	2013-02-27	Dutch
UCB_ResultsFY2012_en.pdf Earnings Release FY 2012	2013-02-27	English
UCB_ResultsFY2012_fr.pdf Annual Report FY 2012	2013-02-27	French
UCB_ResultsFY2012_nl.pdf Earnings Release FY 2012	2013-02-27	Dutch
UCB tozadenant UK Regulatory Filings	2013-02-26	English
UCB tozadenant FR M&A Activity	2013-02-26	French
UCB tozadenant NL Capital/Financing Update	2013-02-26	Dutch
Convocation Extraordinary General Meeting 25032013.pdf AGM Information	2013-02-22	English
Convocation Assemblée Générale Extraordinaire 25032013.pdf AGM Information	2013-02-22	French
Oproeping Buitengewone Algemene Vergadering 25032013.pdf AGM Information	2013-02-22	Dutch
Acceleration of Fracture Healing with CDP7851/AMG785 will not move into phase 3 Regulatory Filings	2013-02-11	English
L’accélération de la consolidation osseuse avec CDP7851/AMG785 n’entrera pas en phase 3 Regulatory Filings	2013-02-11	French
Versnelde breukgenezing met CDP7851/AMG785 niet naar fase 3 Regulatory Filings	2013-02-11	Dutch
UCB: Accelerating focus on the patient Regulatory Filings	2013-02-05	English
UCB toujours plus centré sur le patient Board/Management Information	2013-02-05	French
UCB: steeds meer aandacht voor patiënt Board/Management Information	2013-02-05	Dutch
UCB_PSO_press release_final UK Board/Management Information	2013-02-05	English
UCB_PSO_press release_final FR Board/Management Information	2013-02-05	French
UCB_PSO_press release_final NL Board/Management Information	2013-02-05	Dutch

Filings by year

2026 65 filings
2025 123 filings
2024 167 filings
2023 37 filings
2022 151 filings
2021 168 filings
2020 205 filings
2019 133 filings
2018 116 filings
2017 125 filings
2016 93 filings
2015 84 filings
2014 118 filings
2013 132 filings
2012 147 filings
2011 155 filings
2010 3 filings
2006 1 filing